Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Share buyback would send a very negative signal to the market, they raised capital to accelerate the clinical programs not prop up the share price for short term daytraders and investors
How about the BoD buying shares back, using some of the placing money?
Or would that send out wrong signals?
Y-Alam - I also agree with you that the share consolidation added to the great Friday price frenzy and confusion.
But I don't think the fund-raise itself has created a shorting opportunity. The placees are holders - no loose stock there and other shareholders should count their blessings that money was raised at the price and amount it was.
I agree with you on the impact of the Stem carrot. Created shorter cannon fodder without a rapid valuation consensus, which was not forthcoming.
Also people were still buying due to the stem carrot and thought price would not drop. Shorters dream
There is always selling after placings...a lot believe the the placing shares are pre sold....but a placing of that size???then there was the confusion with the share consolidation....which sent the share to at one point $12 if I remember correctly.......they tried to do a lot at same time. But also saw an opportunity to raise at a high price.
Roker which bit?
Hi Y-Alam
Why so do you think?
The mother of all placings at the top...gave the shorters a gift
Happy ish...I did say I didn't know how they could do it...whimax did say the same...plus the small free float.
Happyish
How irritating, you beat me to it!
1. The $57m fund-raising was a game-changer. Gives the company time and protection against short-term bullying and funds two years of portfolio development.
2. Why would GC, Emery, Altium and Morris Silverman (a big US healthcare philanthropic foundation) give this away? Not going to happen.
My other comment would be that this was an open goal for shorters after the huge run up in the share price a few Fridays ago. It went too far too quickly for probably a number of reasons and a lot of investors understandably came in at £2 plus. Some of these are easy targets for disciplined shorters who know when a share price has been extended. The StemPrintER announcement delay was a gift to them and got them a bridgehead. They aren't necessarily trying to get stock for their rich friends, they are probably just taking money from the impatient.
I used to invest in two types of shorting funds when I was a listed fund manager. One type looked for frauds, structural declines and catastrophic collapses. The other types were short-term opportunists who would have a go when they saw a chance. This falls into the latter category.
There is no way I would sell one share at these levels knowing what I know about TILS.
I meant a much longer prolonged period of pain. Clearly we’ve had enough of pain since placing
Yes, another bad day at the Office. Not long til Stem vote and shorts will need to close at some point.
Don’t see a painful drag down and purchase by Exact as:
1) have cash from placing to tough it out
2) Gabrielle holds the majority of shares.
As was recommended to me after the placing, maybe it’s time for switching off and coming back in a month.
As always, GLA